Amyloid deposition and cognition in older adults: The effects of premorbid intellect

Archives of Clinical Neuropsychology

Volumn 28, Issue 7, 2013, Pages 665-671

  Duff, Kevin ^a   Foster, Norman L ^a   Dennett, Kathryn ^a   Hammers, Dustin B ^a   Zollinger, Lauren V ^b   Christian, Paul E ^b   Butterfield, Regan I ^b   Beardmore, Britney E ^b   Wang, Angela Y ^a   Morton, Kathryn A ^b   Hoffman, John M ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Alzheimer's disease; Amyloid; Neuroimaging; Neuropsychology; Premorbid intellect

Indexed keywords

AMYLOID;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; COGNITION; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; METABOLISM; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PATHOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREMORBID INTELLECT; SCINTISCANNING; VERY ELDERLY;

ALZHEIMER'S DISEASE; AMYLOID; NEUROIMAGING; NEUROPSYCHOLOGY; PREMORBID INTELLECT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84890403096     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1093/arclin/act047     Document Type: Article

References (21)

1. Citron, M. (2010). Alzheimer's disease: Strategies for disease modification. Nature Reviews: Drug Discovery, 9 (5), 387-398
2. Duff, K. (2010). Predicting premorbid memory functioning in older adults. Applied Neuropsychology, 17 (4), 278-282
3. Fleisher, A. S., Chen, K., Liu, X., Roontiva, A., Thiyyagura, P., Ayutyanont, N., et al. (2011). Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Archives of Neurology, 68 (11), 1404-1411
4. Hardy, J.,&Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297 (5580), 353-356
5. Jefferson, A. L., Gibbons, L. E., Rentz, D. M., Carvalho, J. O., Manly, J., Bennett, D. A., et al. (2011). A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. Journal of the American Geriatrics Society, 59 (8), 1403-1411
6. Lundqvist, R., Lilja, J., Thomas, B., Lotjonen, J., Villemagne, V., Rowe, C., et al. (in press). Implementation and validation of an adaptive template registration method for [18F]flutemetamol imaging data. Journal of Nuclear Medicine
7. Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., et al. (2009). Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain, 132 (Pt 5), 1310-1323
8. Nelissen, N., Van Laere, K., Thurfjell, L., Owenius, R., Vandenbulcke, M., Koole, M., et al. (2009). Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. Journal of Nuclear Medicine, 50 (8), 1251-1259
9. Perrotin, A., Mormino, E. C., Madison, C. M., Hayenga, A. O., & Jagust, W. J. (2012). Subjective cognition and amyloid deposition imaging: A Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Archives of Neurology, 69 (2), 223-229
10. Pike, K. E., Savage, G., Villemagne,V. L., Ng, S., Moss, S. A., Maruff, P., et al. (2007). Beta-amyloid imaging and memoryin non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain, 130 (Pt 11), 2837-2844
11. Randolph, C. (1998). Repeatable Battery for the Assessment of Neuropsychological Status. San Antonio, TX: The Psychological Corporation
12. Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., et al. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67 (3), 353-364
13. Rodrigue, K. M., Kennedy, K. M., Devous, M. D., Sr, Rieck, J. R., Hebrank, A. C., Diaz-Arrastia, R., et al. (2012). Beta-Amyloid burden in healthy aging:Regional distribution and cognitive consequences. Neurology, 78 (6), 387-395
14. Roe, C. M., Mintun, M. A., D'Angelo, G., Xiong, C., Grant, E. A., & Morris, J. C. (2008). Alzheimer disease and cognitive reserve: Variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Archives of Neurology, 65 (11), 1467-1471
15. Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiological Aging, 31 (8), 1275-1283
16. Stern, Y. (2006). Cognitive reserve and Alzheimer disease. Alzheimer Disease and Associated Disorder, 20 (2), 112-117
17. Thurfjell, L., Lotjonen, J., Lundqvist, R., Koikkalainen, J., Soininen, H.,Waldemar, G., et al. (2012). Combination of biomarkers: PET [F]Flutemetamol Imaging and structural MRI in Dementia and Mild Cognitive Impairment. Neuro-degenerative Diseases, 10 (1-4), 246-249
18. Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., et al. (2010). 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Annals of Neurology, 68 (3), 319-329
19. Vemuri,P.,Weigand, S. D., Przybelski, S. A.,Knopman, D. S., Smith, G. E., Trojanowski, J. Q., et al. (2011).Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition. Brain, 134 (Pt 5), 1479-1492
20. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., et al. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: Report of the InternationalWorking Group on Mild Cognitive Impairment. Journal of International Medicine, 256 (3), 240-246
21. Wolk, D. A., Grachev, I. D., Buckley, C., Kazi, H., Grady, M. S., Trojanowski, J. Q., et al. (2011). Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Archives of Neurology, 68 (11), 1398-1403.